You are here: a director was appointed on your Dutch entity without the shareholder or sponsor approval your governing documents require, and a private equity sponsor holds board or consent rights that this appointment may have bypassed. Three routes are open: ratify, contest, or negotiate a standstill with the sponsor. A limitation period runs, and each week narrows which of the three remains available to you.
What happens if nothing is done
A defectively appointed director keeps acting: signing, voting at board level, binding the company to counterparties. Every decision that director takes while the defect stands is exposed to challenge, and a sponsor with consent rights has standing to raise it later, at the moment it suits them least. Under Dutch law, an appointment made without the required corporate approval does not automatically become valid with time; it becomes harder to unwind cleanly, because third parties have relied on it. The Dutch Commercial Register, the Handelsregister (Trade Register) kept by KVK, will show this director as registered, which does not cure the underlying defect and does not protect the company from a later challenge.
The three routes open to you
| Route | What it does | Typical timeframe | Who acts |
|---|---|---|---|
| Ratification | A fresh, properly convened resolution confirms the appointment retroactively, closing the gap for future acts | Days to a few weeks, depending on convening notice periods | The general meeting or the body the articles designate |
| Negotiated standstill | The sponsor agrees not to challenge the appointment for a defined period while the company remedies its documents | One to three weeks to agree, longer to implement | The company and the sponsor, usually through counsel on each side |
| Court test | The sponsor, or the company itself, asks a Dutch court to rule on the validity of the appointment and any acts taken under it | Months, not weeks | The Enterprise Chamber or the competent civil court, on application |
Ratification is the fastest route and the one most sponsors prefer, because it protects the deal timeline they are working to. A court test is the route a sponsor takes when the underlying dispute is not really about the appointment but about control, and the defect is the lever. The choice between the three depends on what the sponsor's own agreement says about consent rights, and on whether the acts already taken under the defective appointment can practically be unwound.
What we would need to see before advising
- The articles of association currently in force, and any amendment history relevant to the board appointment power.
- The shareholders' or investment agreement provisions on board composition and consent rights held by the sponsor.
- The resolution, or the absence of one, that purported to appoint the director.
- The Handelsregister filing history for this director, including the filing date relative to the resolution.
- Any acts already taken by the director since appointment that a counterparty or the sponsor could point to.
The deadline that runs
A limitation period applies to challenges of this kind under the applicable Dutch rules, and it starts running from the point the defect could reasonably have been discovered, not from the appointment date itself. Where the sponsor's own consent right was the one bypassed, the sponsor's knowledge of the appointment is usually the trigger. We do not state the specific term here without the file in front of us, because the correct period depends on which provision was breached and which corporate body should have acted. Waiting to establish that fact is itself the risk.
What this does not cover
- It does not cover a dispute about the sponsor's commercial terms, only the corporate validity of the appointment itself.
- It does not cover appointments in jurisdictions other than the Netherlands, even where the same sponsor holds parallel rights elsewhere.
- It does not tell you whether your specific appointment is defective; it tells you the routes available once a defect is established.
- It does not cover the drafting of a new shareholders' agreement, only the immediate question of curing or contesting this appointment.
Questions
Does registering the director with the Trade Register make the appointment valid?
No. The Handelsregister (Trade Register) records what has been reported to it; it does not test whether the underlying corporate resolution met the requirements in the articles or the shareholders' agreement. A registered appointment can still be defective.
Can the sponsor simply veto the director after the fact?
A sponsor cannot unilaterally remove a validly appointed director outside the process the articles set out, but a sponsor with a genuine consent right that was bypassed can challenge the validity of the appointment itself, which is a different route with a different outcome.
What happens to contracts the director already signed?
Acts taken by a defectively appointed director are not automatically void, but they are exposed to challenge, particularly where the counterparty knew or should have known of the defect. Ratification closes this exposure going forward; it does not automatically retroactively cure every prior act without a further step.
Is ratification always available?
Ratification requires the body that should have acted originally, typically the general meeting, to pass a valid resolution now. It is usually available unless the sponsor's consent right makes that resolution itself conditional on approval the sponsor is withholding.
Does this apply the same way to a supervisory board appointment?
The mechanics differ depending on whether the appointment sits with the general meeting, a supervisory board, or a board seat reserved by contract to the sponsor. The route analysis in this brief applies to all three, but the specific body whose resolution is missing changes which route is fastest.
About this analysis
Charlotte Roos, tax and structuring. This brief covers corporate law and governance questions arising from board appointment defects on Dutch entities with an institutional cap table; it does not extend to tax structuring questions the same appointment might raise separately.
Next step
A 30-minute scoping call establishes which of the three routes fits your file: bring the articles, the shareholders' agreement, and the resolution or its absence, and you leave with the route and the realistic timeframe. Where the underlying entity structure itself needs independent verification before any route is chosen, a structure report sets out the current corporate position from the register up, at a fixed price and delivery time stated on that page.
Last legal review: 2026-09-30
Related reading
A dividend was paid and the company cannot meet its debts, with a private equity sponsor on the cap table. The tax authority proposes a correction on intra-group interest, in a regulated setting. Directors and officers data on a German entity. A board risk review.